Beibei Hu

First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors

Sarina A. Piha‐Paul, Jasgit C. Sachdev, Minal Barve et al. · Clinical Cancer Research · 2019 · 159 citations

Medicine, Oncology, Pharmacology +16

Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir

Rajeev Menon, Prajakta Badri, Tianli Wang et al. · Journal of Hepatology · 2015 · 125 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL‐2 inhibitor, in patients with non‐Hodgkin lymphoma

Suresh Agarwal, Ahmed Hamed Salem, Alexey V. Danilov et al. · British Journal of Clinical Pharmacology · 2016 · 103 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Evaluation of Rifampin's Transporter Inhibitory and CYP3A Inductive Effects on the Pharmacokinetics of Venetoclax, a BCL‐2 Inhibitor: Results of a Single‐ and Multiple‐Dose Study

Suresh Agarwal, Beibei Hu, David Chien et al. · The Journal of Clinical Pharmacology · 2016 · 96 citations

Medicine, Pharmacokinetics, Pharmacology +9

High-order lumps, high-order breathers and hybrid solutions for an extended (3 + 1)-dimensional Jimbo–Miwa equation in fluid dynamics

Han-Dong Guo, Tie-Cheng Xia, Beibei Hu · Nonlinear Dynamics · 2020 · 82 citations

Natural Sciences, Mathematics, Differential Equations +5